For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures. Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The Cardiopulmonary Autotransfusion System market revenue was 536.55 Million USD in 2022, and will reach 702.23 Million USD in 2028, with a CAGR of 4.59% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Cardiopulmonary Autotransfusion System industry, and breaks down according to the type, application, and consumption area of Cardiopulmonary Autotransfusion System. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Cardiopulmonary Autotransfusion System in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Cardiopulmonary Autotransfusion System market covered in Chapter 11:
Haemonetics
Terumo
Atrium Medical
LivaNova
Medtronic
Redax
Sarstedt
Stryker
Global Blood Resources
Fresenius Kabi
Advancis Surgical
In Chapter 3, on the basis of types, the Cardiopulmonary Autotransfusion System market from 2018 to 2028 is primarily split into:
Washed ATS
Unwashed ATS
In Chapter 4, on the basis of applications, the Cardiopulmonary Autotransfusion System market from 2018 to 2028 covers:
Great Organ Transplant Surgery
Heart Surgery
Other Surgery
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028